1. Mucuna laticifera: unprecedented L-dopa content and its role in neurodegenerative and inflammatory conditions.
- Author
-
Thamke, Viresh, Suryawanshi, Suresh, Aware, Chetan, Mali, Pratibha, Shinde, Balkrishna, Patil, Devashree, Rane, Manali, Chaudhari, Ashvini, Tapase, Savita, and Jadhav, Jyoti
- Subjects
- *
DOPA , *CARRAGEENANS , *PARKINSON'S disease , *AYURVEDIC medicine , *GENE expression , *PLANT species , *DOPAMINE - Abstract
Genus Mucuna encompasses several plant species renowned for their utilization in traditional Ayurvedic medicine for the treatment of Parkinson's disease, chiefly due to their exceptionally high L-dopa content relative to other plants. However, limited information exists regarding Mucuna laticifera, a newly identified species within the Mucuna genus. This study unveils a remarkable L-dopa content of 174.3 mg/g in M. laticifera seeds, surpassing all previously documented Mucuna species. Moreover, this research marks the first documentation of L-dopa, flavonoids, and phenolics within M. laticifera seeds. Furthermore, the aqueous extract derived from these seeds exhibits robust antioxidant properties. Investigation into its anti-inflammatory potential reveals a significant reduction in paw swelling and neutrophil infiltration at inflammatory sites in a carrageenan-induced rat model. Gene expression analysis utilizing a rat paw model demonstrates that the seed extract significantly downregulates the expression of various inflammation-related genes compared to carrageenan-treated rats. Collectively, these findings clearly substantiate the anti-inflammatory activity of M. laticifera seed extract. The exceptional L-dopa content combined with its anti-inflammatory properties position M. laticifera seeds as a promising therapeutic option for neurodegenerative diseases like Parkinson's, as well as various inflammatory conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF